Search Results - Funke, V.M.

  • Showing 1 - 5 results of 5
Refine Results
  1. 1
    Allogeneic hematopoietic stem cell transplantation from an alternative stem cell source in Fanconi anemia patients: analysis of 47 patients from a single institution

    Allogeneic hematopoietic stem cell transplantation from an alternative stem cell source in Fanconi anemia patients: analysis of 47 patients from a single institution by de Medeiros, C R, Bitencourt, M A, Zanis-Neto, J, Maluf, E C P, Carvalho, D S, Bonfim, C S, Funke, V M, Setubal, D C, Farah, N, Pasquini, R

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Brazilian Workshop on Diagnosis, Classification and Assessment of Severity of Chronic Graft-Versus-Host Disease According to the Criteria of the National institutes of Health

    Brazilian Workshop on Diagnosis, Classification and Assessment of Severity of Chronic Graft-Versus-Host Disease According to the Criteria of the National institutes of Health by Bouzas, L.F.S, de Cassia Tavares, R.B, Silva, M.M, Moreira, M.C.R, Vigorito, A.C, Funke, V.M, Mauad, M.A, Correa, M.E.P, Souza, C.V, Nunes, E, Ferrari, A, Paixao, A, Martins, T, Pallottino, E, Flowers, M.E

    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Allogeneic hematopoietic stem cell transplantation from an alternative stem cell source in Fanconi anemia patients: analysis of 47 patients from a single institution

    Allogeneic hematopoietic stem cell transplantation from an alternative stem cell source in Fanconi anemia patients: analysis of 47 patients from a single institution by Medeiros, C.R. de, Bitencourt, M.A., Zanis-Neto, J., Maluf, E.C.P., Carvalho, D.S., Bonfim, C.S., Funke, V.M., Setubal, D.C., Farah, N., Pasquini, R.

    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Low incidence of acute graft versus host disease and reduced early mortality in CP-CML patients transplanted using CSA, MTX and MP as immunoprophylaxis

    Low incidence of acute graft versus host disease and reduced early mortality in CP-CML patients transplanted using CSA, MTX and MP as immunoprophylaxis by Funke, V.M., Setubal, D.C., Ruiz, J., Lima, D.H., Bonfim, C.M., Bitencourt, M.A., Zanis-Neto, J., de Medeiros, C.R., Pasquini, R.

    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Gleevec as therapy for relapsed Chronic Myeloid Leukemia (CML) and Ph+ Acute Lymphoblastic Leukemia (ALL) after Bone Marrow Transplantation (BMT)

    Gleevec as therapy for relapsed Chronic Myeloid Leukemia (CML) and Ph+ Acute Lymphoblastic Leukemia (ALL) after Bone Marrow Transplantation (BMT) by Funke, V.M., Samir, N., Michel, O.M., Henrique, B., Nelma, C., Fernanda, L., Nelson, H., Marci, P., de Lima, D.H., Setubal, D.C., Jefferson, R., Bonfim, C.M., Bitencourt, M.A., de Medeiros, C.R., Zanis, J., Pasquini, R.

    Get full text
    Article
    Save to List
    Saved in:

Search Tools: